Investigation of the impact of pharmacokinetic variability and uncertainty on risks predicted with a pharmacokinetic model for chloroform

Toxicology

Volumn 111, Issue 1-3, 1996, Pages 289-303

  Allen, B C ^a   Covington, T R ^a   Clewell, H J ^a  

^a ICF INTERNATIONAL   (United States)

Author keywords

Chloroform; Pharmacokinetic modeling; Risk assessment; Uncertainty; Variability

Indexed keywords

CHLOROFORM;

CANCER RISK; CONFERENCE PAPER; CYTOTOXICITY; HUMAN; MODEL; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RISK ASSESSMENT; TOXICOKINETICS;

EID: 0030056460     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0300-483X(96)03383-5     Document Type: Conference Paper

References (25)

1. P. Astrand K. Rodahl Textbook of Work Physiology 1970 McGraw-Hill New York 158 208
2. B.D. Beck R.B. Conolly M.L. Dourson D. Guth D. Hattis C. Kimmel S.C. Lewis Improvements in quantitative noncancer risk assessment Fundam. Appl. Toxicol. 20 1993 1 14
3. P.J. Bickel K.A. Doksum Mathematical Statistics 1977 Holden-Day San Francisco
4. K.T. Bogen R.C. Spear Integrating uncertainty and interindividual variability in environmental risk assessment Risk Anal. 7 1987 427
5. F.Y. Bois L. Zeise T.N. Tozer Precision and sensitivity of pharmacokinetic models for cancer risk assessment: tetrachloroethylene in mice, rats, and humans Toxicol. Appl. Pharmacol. 102 1990 300 315
6. H.J. Clewell Coupling of computer modeling with in vitro methodologies to reduce animal usage in toxicity testing Toxicol. Lett. 68 1993 101 117
7. H.J. Clewell The use of physiologically based pharmacokinetic modeling in risk assessment: a case study with methylene chloride S. Olin W. Farland C. Park L. Rhomberg R. Scheuplein T. Starr J. Wilson Low-Dose Extrapolation of Cancer Risks: Issues and Perspectives 1995 ILSI Press Washington, DC
8. H.J. Clewell T. Lee R.L. Carpenter Sensitivity of physiologically based pharmacokinetic models to variation in model parameters: methylene chloride Risk Anal. 14 1994 521 531
9. R.B. Corley A.M. Mendrala M.L. Gargas M.E. Andersen R.B. Conolly D. Staats R.H. Reitz Development of a physiologically based pharmacokinetic model for chloroform Toxicol. Appl. Pharmacol. 103 1990 512
10. K.S. Crump An improved procedure for low-dose carcinogenic risk assessment from animal data J. Environ. Pathol. Toxicol. 5 1984 339 348
11. Environmental Protection Agency (EPA) Reference physiological parameters in pharmacokinetic modeling EPA/600/6-88/004 1988 Office of Health and Environmental Assessment Washington, DC
12. A.B. Eschenbrenner E. Miller Induction of hepatomas in mice by repeated oral administration of chloroform with observations on sex differences J. Natl. Cancer Inst. 2 1945 251
13. D. Farrar B.C. Allen K.S. Crump A.M. Shipp Evaluation of uncertainty in input parameters to pharmacokinetic models and the resulting uncertainty in output Toxicol. Lett. 49 1989 371
14. J.M. Gearhart D.A. Mahle R.J. Greene C.S. Seckel C.D. Flemming J.W. Fisher H.J. Clewell Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effect on PBPK model predictions in a risk assessment for perchloroethylene (PCE) Toxicol. Lett. 68 1993 131 144
15. R. Heywood R.J. Sortwell P.R.B. Noel A.E. Street D.E. Prentice F.J.C. Roe P.F. Wadsworth A.N. Worden N.J. Van Abbe Safety evaluation of toothpaste containing chloroform. III. Long-term studies in beagle dogs J. Environ. Pathol. Toxicol. 2 1979 835
16. ILSI Physiological parameter values for PBPK models ILSI Risk Science Institute report prepared for EPA/OHEA 1994 International Life Sciences Institute Washington, DC
17. T.A. Jorgenson E.F. Meierhenry C.J. Rushbrook R.J. Bull M. Robinson Carcinogenicity of chloroform in drinking water to male Osborne Mendel Rats and female B6C3F1 mice Fundam. Appl. Toxicol. 5 1985 760
18. J.L. Larson D.C. Wolf B.E. Butterworth Acute hepatic and nephrotoxic effects of chloroform in male F-344 rats and female B6C3F1 mice Fundam. Appl. Toxicol. 20 1993 302 315
19. J.L. Larson D.C. Wolf B.E. Butterworth Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: comparison of administration by gavage in corn oil vs. ad libitum in drinking water Fundam. Appl. Toxicol. 22 1994 90 102
20. NCI Carcinogenesis Bioassay of Chloroform U.S. Department of Commerce National Technical Information Service Publication No. PB264018/AS 1976 NCI Bethesda, MD
21. A.K. Palmer A.E. Street F.J.C. Roe A.N. Worden N.J. Van Abbe Safety evaluation of toothpaste containing chloroform. II. Long-term studies in rats J. Environ. Pathol. Toxicol. 2 1979 821
22. C.J. Portier N.L. Kaplan Variability of safe dose estimates when using complicated models of the carcinogenic process. A case study: methylene chloride Fundam. Appl. Toxicol. 13 1989 533 544
23. R.H. Reitz A.L. Mendrala R.A. Corley J.F. Quast M.L. Gargas M.E. Andersen D.A. Staats R.B. Conolly Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling Toxicol. Appl. Pharmacol. 105 1990 443
24. F.J.C Roe A.K. Palmer A.N. Worden N.J. Van Abbe Safety evaluation of toothpaste containing chloroform. I. Long-term studies in mice J. Environ. Pathol. Toxicol. 2 1979 799
25. USEPA Health Assessment Document for Chloroform Final Report, EPA/600/8-84/004F U.S. Department of Commerce National Technical Information Service Publication No. PB86-105004 1985